Han Y, Byun J, VanLith CJ, Cooley MA, Shaw VR, Hatia RI, Ahmed FY, Giama NH, Ali HM, Campbell NA, Hassan M, Andersen JB, Ankoma-Sey V, Banales JM, Bujanda L, Bathe OF, Bekaii-Saab TS, Borad MJ, Björkström NK, Chan CHF, Cleary SP, Cornillet M, Folseraas T, Galle PR, Genkinger JMet al.(2026) Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses Hepatology(in press) DOI 10.1097/HEP.0000000000001699, PubMed 41627892
Holmer M, Ingre M, Färkkilä M, Ponsioen C, Mol B, Schramm C, Folseraas T, Wiencke K, Cazzagon N, Catanzaro E, Molinaro A, Nilsson E, Vessby J, Kechagias S, Nyhlin N, Werner M, Bergquist A(2025) Reply: Competing risk and surveillance thresholds for HCC in patients with PSC Hepatology(in press) DOI 10.1097/HEP.0000000000001651, PubMed 41405465
Banales JM, Rodrigues PM, Affò S, Andersen JB, Aspichueta P, Boulter L, Bridgewater J, Calvisi DF, Cardenas A, Cardinale V, Carpino G, Coulouarn C, Dopazo C, Edeline J, Fabris L, Folseraas T, Forner A, Goeppert B, Heikenwalder M, Kendall TJ, Khan SA, Klümpen HJ, Koerkamp BG, Lamarca A, Lindsey Set al.(2025) Cholangiocarcinoma 2026: status quo, unmet needs and priorities Nat Rev Gastroenterol Hepatol, 23(1), 65-96 DOI 10.1038/s41575-025-01153-w, PubMed 41372578
